Sex Selection Moves to Consumer Culture
By Marcy Darnovsky,
Genetic Crossroads
| 08. 20. 2003
Ads for "Family Balancing" in The New York Times
Several times over the past few months, a small
but striking ad from a Virginia-based fertility clinic has appeared
in the Sunday Styles section of The New York Times. Alongside
a smiling baby, its boldface headline asks, "Do You Want
To Choose the Gender Of Your Next Baby?"
If so, the ad continues, you can join "prospective parents…from
all over the world" who come to the Genetics & IVF
Institute (GIVF) for an "exclusive scientifically-based
sperm sorting gender selection procedure." The technique,
known by the trademarked name MicroSort, is offered as a way
to choose a girl or boy either for the "prevention of genetic
diseases" (selecting against the sex affected by an X-linked
or Y-linked condition) or for "family balancing" (selecting
for a girl in a family that already has one or more boys, or
vice versa).
GIVF
has been promoting MicroSort on its website for several years,
and a few other fertility clinics offer other "family balancing"
methods online. But the MicroSort ads in The New York Times
represent a bolder and higher-profile approach. They mark the...
Related Articles
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Peter Aldhous, Scientific American | 07.02.2024
In June a notice posted on the website of the journal Nature set a new scientific record. It withdrew what is now the most highly cited research paper ever to be retracted.
The study, published in 2002 by Catherine Verfaillie...
By Emma McDonald Kennedy
| 07.11.2024
Louise Perry’s recent article in The Spectator cautions against “The quiet return of eugenics,” a threat she locates in preimplantation genetic testing for polygenic disorders. The technology is billed as a way for parents undergoing IVF to select which embryo to implant based on information about each embryo’s genetic risk factors and traits. These reports, she says, give parents “a very full picture of the adult that embryo could become”––from their child’s risk of developing different diseases to their “likely...
By Sara Luterman, The 19th News | 05.23.2024
Historically, the disability and reproductive rights movements have operated separately, “just ignoring each other,” as one advocate put it, as they pursued aims that at times felt contradictory: While one movement fought for full abortion access, the other sought for...